Jpmorgan Chase & CO Calyxt, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.13 - $0.2 $2 - $3	-19 Reduced 63.33%	11 $0
Q3 2022 Nov 14, 2022	BUY	$0.17 - $0.3 $3 - $5	19 Added 172.73%	30 $0
Q1 2022 May 11, 2022	SELL	$1.02 - $2.46 $50,895 - $122,749	-49,898 Reduced 99.98%	11 $0
Q4 2021 Feb 10, 2022	BUY	$2.06 - $4.05 $41,529 - $81,648	20,160 Added 67.77%	49,909 $106,000
Q3 2021 Nov 12, 2021	BUY	$3.18 - $5.08 $94,601 - $151,124	29,749 New	29,749 $100,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.